AIHealthcare

Vivodyne is a private biotechnology company developing an AI-enabled preclinical drug-discovery platform based on lab-grown, functional human tissues. Its system combines human-tissue engineering, microfluidic organ-on-chip and organoid technologies, robotic high-throughput experimentation, imaging, and machine-learning analysis to generate human-relevant data before clinical trials. The company positions its platform as an alternative or complement to animal testing, aiming to improve prediction of drug efficacy and toxicity and reduce clinical-development risk. Vivodyne serves pharmaceutical and biotechnology companies and is positioned in the emerging human-relevant preclinical testing and AI-for-drug-discovery market; claims about predictive performance, customer adoption, and market leadership are company or investor assertions rather than independently verified market rankings.